Lineage Cell Therapeutics
LCTX
#8556
Rank
$0.28 B
Marketcap
$1.11
Share price
-4.31%
Change (1 day)
-9.02%
Change (1 year)

Lineage Cell Therapeutics - 10-Q quarterly report FY2021 Q1


Text size: